Collegium Pharmaceutical, Inc. (COLL) Stock Total Returns
Growth of $10,000 chart
2021-04-12 to 2026-04-10 to
$
%
%
Loading chart…
Investment Performance
Final Value
$15,564
Total Return
55.64%
CAGR
9.26%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.32% |
| Median | +0.16% |
| Best | +47.19% |
| Worst | -31.10% |
| % of Windows Positive | 50.4% |
1-Year (252 Trading Days)
| Average | +19.29% |
| Median | +20.83% |
| Best | +79.23% |
| Worst | -36.46% |
| % of Windows Positive | 68.1% |
3-Year (756 Trading Days)
| Average | +73.43% |
| Median | +71.37% |
| Best | +151.33% |
| Worst | +22.86% |
| % of Windows Positive | 100.0% |
Risk Metrics
| Maximum Drawdown | -43.99% |
| Average Drawdown | -19.01% |
| Drawdown Duration | 367 Trading Days |
| Sortino Ratio | 0.63 |
| Calmar Ratio | 0.21 |
| CVaR (5%) | -5.30% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -23.39% (-62.21% ann.) | $2339.09 | $0.00 | $0.00 | $0.00 |
| 2025 | +61.61% | +$6160.55 | $0.00 | $0.00 | $0.00 |
| 2024 | -6.92% | $692.01 | $0.00 | $0.00 | $0.00 |
| 2023 | +32.67% | +$3267.24 | $0.00 | $0.00 | $0.00 |
| 2022 | +24.20% | +$2419.70 | $0.00 | $0.00 | $0.00 |
| 2021 | -6.74% | $673.99 | $0.00 | $0.00 | $0.00 |
| 2020 | -2.67% | $267.25 | $0.00 | $0.00 | $0.00 |
| 2019 | +19.86% | +$1986.02 | $0.00 | $0.00 | $0.00 |
| 2018 | -6.99% | $698.81 | $0.00 | $0.00 | $0.00 |
| 2017 | +18.56% | +$1856.13 | $0.00 | $0.00 | $0.00 |
| 2016 | -43.38% | $4338.18 | $0.00 | $0.00 | $0.00 |
| 2015 partial | +123.76% (+244.19% ann.) | +$12375.92 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | May 7, 2015 – February 19, 2020 | +94.39% | +14.89% | +$9438.57 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -41.13% | -99.76% | $4112.66 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +20.70% | +35.35% | +$2070.03 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -13.15% | -12.52% | $1315.02 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +9.33% | +9.93% | +$932.88 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +94.08% | +43.01% | +$9408.10 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 10, 2026 | -8.54% | -5.57% | $853.53 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.